Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis
- PMID: 32566566
- PMCID: PMC7290630
- DOI: 10.21037/atm-20-3324
Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis
Abstract
Background: COVID-19, a disease caused by SARS-CoV-2 coronavirus, has now spread to most countries and regions of the world. As patients potentially infected by SARS-CoV-2 need to visit hospitals, the incidence of nosocomial infection can be expected to be high. Therefore, a comprehensive and objective understanding of nosocomial infection is needed to guide the prevention and control of the epidemic.
Methods: We searched major international and Chinese databases: Medicine, Web of Science, Embase, Cochrane, CBM (China Biology Medicine disc), CNKI (China National Knowledge Infrastructure) and Wanfang database for case series or case reports on nosocomial infections of COVID-19, SARS (severe acute respiratory syndromes) and MERS (Middle East respiratory syndrome) from their inception to March 31st, 2020. We conducted a meta-analysis of the proportion of nosocomial infection patients in the diagnosed patients, occupational distribution of nosocomial infection medical staff.
Results: We included 40 studies. Among the confirmed patients, the proportions of nosocomial infections with early outbreaks of COVID-19, SARS, and MERS were 44.0%, 36.0%, and 56.0%, respectively. Of the confirmed patients, the medical staff and other hospital-acquired infections accounted for 33.0% and 2.0% of COVID-19 cases, 37.0% and 24.0% of SARS cases, and 19.0% and 36.0% of MERS cases, respectively. Nurses and doctors were the most affected among the infected medical staff. The mean numbers of secondary cases caused by one index patient were 29.3 and 6.3 for SARS and MERS, respectively.
Conclusions: The proportion of nosocomial infection in patients with COVID-19 was 44% in the early outbreak. Patients attending hospitals should take personal protection. Medical staff should be awareness of the disease to protect themselves and the patients.
Keywords: COVID-19; meta-analysis; nosocomial infection; rapid review.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3324). MSL serves as the unpaid editorial board member of Annals of Translational Medicine from Nov 2019 to Oct 2021. The other authors have no conflicts of interest to declare.
Figures








References
-
- National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) [J/OL] . Chin Med J,2020,133 (2020-03-13). Available online: http://rs.yiigle.com/yufabiao/1184760.htm. doi: 10.3760/cma.j.issn.0366-6999.2020.0027. - DOI
-
- WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020[Internet]. World Health Organization;c2020 [cited 2020 Apr 13]. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous